Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.73 USD
Change Today +0.01 / 0.58%
Volume 362.6K
AVEO On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - aveo pharmaceuticals inc (AVEO)

Name (Connections)Board RelationshipsTitleKey Developments
Kenneth Bate MBA 69 RelationshipsDirector, Chairman of Audit Committee and Member of Compensation CommitteeAVEO Pharmaceuticals, Inc. announced delayed annual 10-K filing
03/16/12
Robert Young M.D. 12 RelationshipsDirector, Chairman of Nominating & Governance Committee and Member of Audit Committee 

Compensation Committee* - aveo pharmaceuticals inc (AVEO)

Name (Connections)Board RelationshipsTitle
Kenneth Bate MBA 69 RelationshipsDirector, Chairman of Audit Committee and Member of Compensation Committee
Henri Termeer 311 RelationshipsLead Outside Director, Member of Nominating & Governance Committee and Member of Compensation Committee
AVEO Compensation vs. Industry
361.6K
364.1K
Chief Executive Officer
Share price activity for AVEO PHARMACEUTICALS INC (AVEO)
52 Week Price Performance
AVEO
Industry Average

Nominating Committee* - aveo pharmaceuticals inc (AVEO)

Name (Connections)Board RelationshipsTitleKey Developments
Robert Young M.D. 12 RelationshipsDirector, Chairman of Nominating & Governance Committee and Member of Audit CommitteeMatthew Dallas, Vice President, Finance, Treasurer and the Principal Accounting Officer Leaves AVEO Pharmaceuticals, Inc., Effective February 6, 2015
01/23/15
Henri Termeer 311 RelationshipsLead Outside Director, Member of Nominating & Governance Committee and Member of Compensation CommitteeAVEO Oncology Appoints Michael N. Needle as Chief Medical Officer
01/9/15

Corporate Governance Committee* - aveo pharmaceuticals inc (AVEO)

Name (Connections)Board RelationshipsTitle
Henri Termeer 311 RelationshipsDirector, Chairman of Audit Committee and Member of Compensation Committee
Robert Young M.D. 12 RelationshipsLead Outside Director, Member of Nominating & Governance Committee and Member of Compensation Committee
AVEO and Competitor
Insiders vs. External
Board
15%
85%
AVEO Pharmaceuticals, Inc.
6%
94%
ArQule Inc.
18%
82%
Bristol-Myers Squibb Company
15%
85%
Exelixis, Inc.
24%
76%
Takeda Pharmaceutical Company Limited
57%
43%
GlaxoSmithKline S.A.E
Insiders
External Board Members

Advisory Committee* - aveo pharmaceuticals inc (AVEO)

Name (Board Relationships)/Title Board Affiliations
Lewis Cantley 88 Relationships
Member of Scientific Advisory Board
No other board affiliations
Lynda Chin 48 Relationships
Member of Scientific Advisory Board
No other board affiliations
Douglas Hanahan 58 Relationships
Member of Scientific Advisory Board
No other board affiliations
Tyler Jacks 82 Relationships
Member of Scientific Advisory Board
No other board affiliations
Charles Sawyers 174 Relationships
Member of Scientific Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AVEO:US $1.73 USD +0.01

AVEO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ArQule Inc $1.62 USD +0.06
Bristol-Myers Squibb Co $67.48 USD -0.19
Exelixis Inc $3.44 USD -0.05
GlaxoSmithKline SAE £11.50 EGP 0.00
Takeda Pharmaceutical Co Ltd ¥5,983 JPY -14.00
View Industry Companies
 

Industry Analysis

AVEO

Industry Average

Valuation AVEO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 30.7x
Price/Book 6.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 12.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AVEO PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.